The gateway to small- and midcap stocks in Scandinavia.
Steen has more than 15 years hands-on expericence in analysing and investing in stocks. He is a weekly contributor and analyst in “Aktieugebrevet”, one of the leading sources of independent analysis in Denmark.
I have a preference for hidden gems in the SmallCap and MidCap sector, where there truly is value to be found with the right effort. Often those stocks are without analyst coverage and it may require some patience before the rest of the markets see the value as well.
The main geografical area is Scandinavia and the portfolio is somehow biased towards the Danish market.
Diversification is the most important rule in the portfolio. The aim is to have a portfolio of 20-30 stocks with weights of 2-5 % at the time of acquisition.
I strive to keep the majority of the portfolio for the long-run, though I will make opportunistic trades based on market fluctuations in and outside of the portfolio to maximize return.
Peter Hildebrandt, also known as “Akademikeren”, has been investing for more than 17 years.
Mainly invests in undervalued technology and biotech stocks and is currently rotating towards dividend stocks in industry energy and shipping.
Performance as of Mid-September is +25% Year-to-Date.
“I am deploying a value approach to my retirement fund. It started out with a cash deposit of 3 x 40.000 DKK in 2001-2003. It is focused on a concept of earning power, derived from Buffet and currently yields +3%. I review all companies at least 4 times a year in conjunction with their fiscal report. Currently my bias is that stocks, expecially biotech is at the high end of their valuation due to excessive M&A activity. I also write in Danish from time to time.”
Andreas, known as Investor1989 on forums like Proinvestor and EuroInvestor, has been providing stock tips and analysis of value stocks with deep fundamental research behind each stock he recommends.
Andreas is privately a portfolio manager at his own Investment company where he Invest in stocks, options, CFD’s etc. with a balanced long/short hedge fund style.
“I will invest with a long term horizon making regularly updates on the stocks i hold and update on financial and conference call updates. I will do analysis everytime i add or dispose a stock in the portfolio.”
I’m a ten year veteran of biotechnology, and currently pursuing my MBA from UCLA. I use my knowledge of the industry and business to make my investing decisions. I look for small to mid-cap biotech companies with innovative research and buy into their company during clinical trials.
Jacob’s approach is to search for that which is undervalued and where the discount to the intrinsic value provides a large margin of safety. He believes sectors that are either out of favor or in distress typically offer the best opportunities. He will usually search in the small cap space as less analyst coverage increases the chance of mispricing.
He is known for his investment blog Hammerinvesting, where he has presented thoroughly researched investment ideas as well as discussing the intricacies of the art of investing. He has been investing for 10 years.
Please note that posts on Scandinavian companies will be written in Danish.